Literature DB >> 19377917

Activation of clotting factors in cancer.

Frederick R Rickles1, Anna Falanga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19377917     DOI： 10.1007/978-0-387-79962-9_3

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  10 in total

1.  Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography.

Authors:  Marina Marchetti; Erika Diani; Hugo ten Cate; Anna Falanga
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

2.  Determining the anti-coagulant-independent anti-cancer effects of heparin.

Authors:  V Solari; E C Jesudason; J E Turnbull; E A Yates
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

3.  Risk of colorectal cancer and clotting factor gene polymorphisms in Moroccan Population.

Authors:  Imane Baghad; Driss Erguibi; Farid Chehab; Sellama Nadifi
Journal:  Int J Adv Res (Indore)       Date:  2017

4.  Brain neoplasms and coagulation-lessons from heterogeneity.

Authors:  Esterina D'Asti; Yi Fang; Janusz Rak
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

5.  Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.

Authors:  Cinzia Giaccherini; Marina Marchetti; Giovanna Masci; Cristina Verzeroli; Laura Russo; Luigi Celio; Roberta Sarmiento; Sara Gamba; Carmen J Tartari; Erika Diani; Alfonso Vignoli; Paolo Malighetti; Daniele Spinelli; Carlo Tondini; Sandro Barni; Francesco Giuliani; Fausto Petrelli; Andrea D'Alessio; Giampietro Gasparini; Filippo De Braud; Armando Santoro; Roberto Labianca; Anna Falanga
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

6.  Real-world features associated with cancer-related venous thromboembolic events.

Authors:  Maija Helena Peippo; Samu Kurki; Riitta Lassila; Olli Mikael Carpén
Journal:  ESMO Open       Date:  2018-07-23

7.  Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.

Authors:  Patricia Gomez-Rosas; Marina Pesenti; Cristina Verzeroli; Cinzia Giaccherini; Laura Russo; Roberta Sarmiento; Giovanna Masci; Luigi Celio; Mauro Minelli; Sara Gamba; Carmen Julia Tartari; Carlo Tondini; Francesco Giuliani; Fausto Petrelli; Andrea D'Alessio; Giampietro Gasparini; Roberto Labianca; Armando Santoro; Filippo De Braud; Marina Marchetti; Anna Falanga
Journal:  TH Open       Date:  2021-02-10

8.  Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer.

Authors:  Axel Rosell; Katherina Aguilera; Yohei Hisada; Clare Schmedes; Nigel Mackman; Håkan Wallén; Staffan Lundström; Charlotte Thålin
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

9.  Risk Factors for Chemotherapy-Associated Venous Thromboses in Gynaecological Oncology Patients.

Authors:  Sandra Nezi-Cahn; Isabel Sicking; Kathrin Almstedt; Marco Battista; Anne-Sophie Heimes; Slavomir Krajnak; Joscha Steetskamp; Annette Hasenburg; Marcus Schmidt
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-06-05       Impact factor: 2.915

10.  Application of Thromboelastography to Predict Lung Cancer Stage.

Authors:  Yaning Zhou; Yijun Guo; Qing Cui; Yun Dong; Xiaoyue Cai; Zhouji Zhang; Xiaoting Wu; Kaiyan Yi; Ming Zhang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.